Bright Minds Biosciences (DRUG) Return on Equity: 2020-2021

  • Bright Minds Biosciences' Return on Equity was N/A to 0.18% in Q2 2021 from the same period last year, while for Jun 2021 it was 0.18%, marking a year-over-year change of. This contributed to the annual value of -0.14% for FY2020, which is N/A change from last year.
  • As of Q2 2021, Bright Minds Biosciences' Return on Equity stood at 0.18%, which was up 184.26% from 0.06% recorded in Q1 2021.
  • In the past 5 years, Bright Minds Biosciences' Return on Equity registered a high of 0.18% during Q2 2021, and its lowest value of 0.06% during Q1 2021.
  • Its 2-year average for Return on Equity is 0.12%, with a median of 0.12% in 2020.